Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Morgonrapport
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
    • Transkriptioner
    • Årsstämmor
    • IPOs
  • InderesTV
  • Portfölj
  • Forum
  • Upptäck
  • Q&A
  • Om oss
    • Bolag under bevakning
    • Teamet
Pressmeddelande

ChemoTech's Proposed Strategic Changes Accepted by Nasdaq First North

Scandinavian ChemoTech

Scandinavian ChemoTech AB (publ) (the "Company") today announces that, based on information disclosed in the Company's press releases published on Tuesday, March 31, ahead of the notice of the Annual General Meeting, Nasdaq Stockholm has communicated its preliminary assessment regarding the Company's proposed strategic changes.

 

Nasdaq Stockholm shares the Company's assessment that the strategic change, as proposed, does not constitute such a fundamental change in operations as referred to in item 2.5.1 of the Nasdaq First North Growth Market Rulebook.

 

Nasdaq Stockholm has, however, emphasized that it reserves the right to revise this assessment should circumstances change.

 

"We are pleased that Nasdaq shares our assessment regarding the proposed changes and that the AGM will be able to decide in May," says Mohan Frick, CEO and Co-founder.

 

Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.